These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26519068)

  • 1. In Vitro Models for Candida Biofilm Development.
    Krom BP; Willems HM
    Methods Mol Biol; 2016; 1356():95-105. PubMed ID: 26519068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditions for optimal Candida biofilm development in microtiter plates.
    Krom BP; Cohen JB; McElhaney-Feser G; Busscher HJ; van der Mei HC; Cihlar RL
    Methods Mol Biol; 2009; 499():55-62. PubMed ID: 19152039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Techniques for antifungal susceptibility testing of Candida albicans biofilms.
    Ramage G; López-Ribot JL
    Methods Mol Med; 2005; 118():71-9. PubMed ID: 15888936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro biofilm formation and relationship with antifungal resistance of Candida spp. isolated from vaginal and intrauterine device string samples of women with vaginal complaints].
    Calışkan S; Keçeli Özcan S; Cınar S; Corakçı A; Calışkan E
    Mikrobiyol Bul; 2011 Oct; 45(4):697-706. PubMed ID: 22090300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex.
    Melo AS; Bizerra FC; Freymüller E; Arthington-Skaggs BA; Colombo AL
    Med Mycol; 2011 Apr; 49(3):253-62. PubMed ID: 21039308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro method to study antifungal perfusion in Candida biofilms.
    Samaranayake YH; Ye J; Yau JY; Cheung BP; Samaranayake LP
    J Clin Microbiol; 2005 Feb; 43(2):818-25. PubMed ID: 15695686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 96 well microtiter plate-based method for monitoring formation and antifungal susceptibility testing of Candida albicans biofilms.
    Pierce CG; Uppuluri P; Tummala S; Lopez-Ribot JL
    J Vis Exp; 2010 Oct; (44):. PubMed ID: 21048668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Candida activity assessment of Pelargonium graveolens oil free and nanoemulsion in biofilm formation in hospital medical supplies.
    Giongo JL; de Almeida Vaucher R; Fausto VP; Quatrin PM; Lopes LQS; Santos RCV; Gündel A; Gomes P; Steppe M
    Microb Pathog; 2016 Nov; 100():170-178. PubMed ID: 27544324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of two different methods for the investigation of in vitro susceptibilities of planktonic and biofilm forming Candida species to antifungal agents].
    Kaynak Onurdağ F; Ozgen S; Abbasoğlu U; Gürcan IS
    Mikrobiyol Bul; 2010 Oct; 44(4):619-31. PubMed ID: 21063974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro screening of antifungal compounds able to counteract biofilm development.
    Girardot M; Imbert C
    Methods Mol Biol; 2014; 1147():187-201. PubMed ID: 24664834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymol inhibits Candida albicans biofilm formation and mature biofilm.
    Braga PC; Culici M; Alfieri M; Dal Sasso M
    Int J Antimicrob Agents; 2008 May; 31(5):472-7. PubMed ID: 18329858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro biofilm formation of Candida albicans and non-albicans Candida species under dynamic and anaerobic conditions.
    Thein ZM; Samaranayake YH; Samaranayake LP
    Arch Oral Biol; 2007 Aug; 52(8):761-7. PubMed ID: 17321487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole.
    Borecká-Melkusová S; Moran GP; Sullivan DJ; Kucharíková S; Chorvát D; Bujdáková H
    Mycoses; 2009 Mar; 52(2):118-28. PubMed ID: 18627475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voriconazole inhibits biofilm formation in different species of the genus Candida.
    Valentín A; Cantón E; Pemán J; Martínez JP
    J Antimicrob Chemother; 2012 Oct; 67(10):2418-23. PubMed ID: 22733651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed biofilms formed by C. albicans and non-albicans species: a study of microbial interactions.
    Santos JD; Piva E; Vilela SF; Jorge AO; Junqueira JC
    Braz Oral Res; 2016; 30():. PubMed ID: 26981754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of Candida albicans biofilm formation on silver-coated vascular grafts.
    Tammer I; Reuner J; Hartig R; Geginat G
    J Antimicrob Chemother; 2014 May; 69(5):1282-5. PubMed ID: 24448486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biofilm inhibition by Cymbopogon citratus and Syzygium aromaticum essential oils in the strains of Candida albicans.
    Khan MS; Ahmad I
    J Ethnopharmacol; 2012 Mar; 140(2):416-23. PubMed ID: 22326355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteinase, phospholipase, biofilm forming abilities and antifungal susceptibilities of Malaysian Candida isolates from blood cultures.
    Tay ST; Abidin IA; Hassan H; Ng KP
    Med Mycol; 2011 Jul; 49(5):556-60. PubMed ID: 21254967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of acetylsalicylic acid (aspirin) on biofilm production by Candida species.
    Stepanović S; Vuković D; Jesić M; Ranin L
    J Chemother; 2004 Apr; 16(2):134-8. PubMed ID: 15216946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro synergism between berberine and miconazole against planktonic and biofilm Candida cultures.
    Wei GX; Xu X; Wu CD
    Arch Oral Biol; 2011 Jun; 56(6):565-72. PubMed ID: 21272859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.